Grifols, S.A. (GRFE.XC)
| Previous close | 9.07 |
| Open | 9.07 |
| Bid | 8.61 x N/A |
| Ask | 9.70 x N/A |
| Day's range | 9.07 - 9.07 |
| 52-week range | 6.62 - 15.78 |
| Volume | |
| Avg. volume | 431 |
| Market cap | 4.934B |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | 100.77 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 03 Jun 2021 |
| 1y target est | N/A |
- Simply Wall St.
Grifols Leads Three Stocks That May Be Priced Below Their Estimated True Value
As global markets exhibit mixed signals with modest gains in the U.S. and challenges in sectors like Chinese real estate, investors are keenly watching for opportunities that might be undervalued. In this environment, identifying stocks such as Grifols that potentially trade below their intrinsic value could offer attractive entry points amidst current market conditions.
- Reuters
Spanish drug maker Grifols will bring in independent directors, chairman tells newspaper
MADRID (Reuters) -Spanish drug maker Grifols, battling a plunge in its share price this year, plans to add independent directors to its audit and compensation committees to improve its governance, its chairman said in a newspaper interview published on Sunday. Grifols' market value has shed billions of euros since short-sheller Gotham City Research released three reports in early January accusing the company of overstating earnings and understating debt. Grifols has repeatedly denied the claims.
- Reuters
UPDATE 2-Europe's STOXX 600 logs weekly gains, US jobs data in focus
Europe's main stock indices were flat on Friday, but notched strong gains over the week that saw record highs from German and French shares, while investors also analysed a U.S. jobs report for clues on the global monetary policy outlook. Technology lost 1.6% after BE Semiconductor slumped 16.1% on a media report that Joint Electron Device Engineering Council lowered certain chip standards which might delay investments into hybrid bonding technology.
